Huiyong Wu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: TACE-HAIC versus HAIC combined with TKIs and ICIs for hepatocellular carcinoma with a high tumor burden-a propensity-score matching comparative study.
Journal: Frontiers in immunology
Published: December 17, 2025
Retrospective analysis of transarterial chemoembolization or hepatic arterial infusion chemotherapy combined with lenvatinib with or without PD-1 inhibitor as first-line therapy for unresectable hepatocellular carcinoma with high tumor burden: a propensity score-matched study.
Journal: Frontiers in immunology
Published: October 02, 2025
TACE-HAIC versus HAIC combined with TKIs and ICIs for hepatocellular carcinoma with a high tumor burden-a propensity-score matching comparative study.
Journal: Frontiers in immunology
Published: July 12, 2025
C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: July 01, 2025
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study.
Journal: Journal of hepatocellular carcinoma
Published: April 23, 2023
CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer: Initial experience in 14 patients.
Journal: Medicine
Published: June 15, 2021
Transarterial Chemoembolization Followed by Radiotherapy Versus Sandwich Treatment for Unresectable or Ablative Hepatocellular Carcinoma.
Journal: Technology in cancer research & treatment
Published: December 28, 2020
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma.
Journal: BMC gastroenterology
Published: September 01, 2017
Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma.
Journal: Journal of surgical oncology
Published: April 28, 2015
Pure transcatheter arterial chemoembolization therapy for intrahepatic tumors causes a shrink in pulmonary metastases of hepatocellular carcinoma.
Journal: International journal of clinical and experimental medicine
Published: November 10, 2014
Last Updated: 09/26/2026